Study to Evaluate Drug-drug Interaction Between Valopicitabine and Ribavirin
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to see if the investigational medication, valopicitabine, is
safe to use in combination with ribavirin, a drug approved by the FDA for treating hepatitis
C infection.